Inscription Capital LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 6,146 shares of the company's stock, valued at approximately $847,000.
Other hedge funds have also made changes to their positions in the company. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health in the 4th quarter valued at approximately $26,000. Promus Capital LLC bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $30,000. Bellwether Advisors LLC bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $32,000. Tompkins Financial Corp raised its stake in shares of Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after purchasing an additional 128 shares in the last quarter. Finally, Lee Danner & Bass Inc. bought a new position in Cardinal Health in the fourth quarter worth $35,000. Institutional investors own 87.17% of the company's stock.
Analyst Ratings Changes
CAH has been the topic of several analyst reports. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Robert W. Baird upped their price objective on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a research note on Friday, May 2nd. UBS Group increased their target price on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Mizuho boosted their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Finally, Morgan Stanley set a $181.00 price target on Cardinal Health and gave the company an "overweight" rating in a research report on Friday, June 13th. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $157.43.
Check Out Our Latest Analysis on CAH
Cardinal Health Price Performance
Shares of CAH stock traded up $0.60 during trading hours on Thursday, reaching $165.51. 2,598,098 shares of the company were exchanged, compared to its average volume of 2,228,577. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $166.03. The stock's fifty day moving average is $148.17 and its two-hundred day moving average is $133.48. The company has a market cap of $39.50 billion, a price-to-earnings ratio of 25.82, a P/E/G ratio of 1.84 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. The firm had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The business's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.08 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.5107 per share. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.23%. The ex-dividend date is Tuesday, July 1st. Cardinal Health's payout ratio is currently 31.51%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.